Despite Washington's reputation for healthcare innovation, accessing GLP-1 treatment in Seattle can still mean navigating insurance hurdles. Wegovy® is the FDA-approved Injectable pen Semaglutide product manufactured by Novo Nordisk. Weight Method offers a separate option: licensed Washington providers evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program starts at $199/month, including the provider evaluation, the medication, ongoing care, and shipping to your Seattle address.
GLP-1 treatment prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Seattle is already seeing results
GLP-1 weight-loss treatment available to eligible patients in Seattle, WA. Weight Method offers compounded semaglutide, prescribed by licensed providers, from $199/month with virtual consultations and direct-to-door shipping.
Semaglutide targets the biological mechanisms involved in sustained weight regulation. By activating GLP-1 receptors in the brain, it can reduce hunger signals and slow gastric emptying. Novo Nordisk developed Wegovy® as the FDA-approved Injectable pen product, taken Once weekly, approved in 2021. Weight Method is a separate program: licensed providers in Washington evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program for eligible Seattle, WA residents starts at $199/month.
Urban residents in Seattle are often surrounded by healthcare options yet still struggle to access GLP-1 treatment. Primary care physicians may not specialize in GLP-1 prescribing, and specialist clinics charge $500+ per visit. Weight Method's all-inclusive compounded Semaglutide program — consultation, medication, and ongoing support at $199/month — is built for the urban patient who values quality and efficiency. Compounded Semaglutide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in Washington and start Wegovy from $199/month.
Get Started NowFree consultation. No commitment.